Related Experiment Video
Updated: Jun 26, 2026
10:38
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
23.2K
Delayed Hemolysis With Parenteral Artesunate
Alfred Awuah1, Punit Jitendra Shah2, Farheen Tariq2
1Houston Methodist Hospital, Houston, TX, USA.
Hospital Pharmacy
|May 22, 2023
Summary
Delayed hemolysis, a rare adverse effect of artesunate (an effective malaria treatment), can occur weeks after therapy. This case report details a patient experiencing this post-treatment complication.
Area of Science:
- Pharmacology
- Hematology
- Infectious Diseases
Background:
- Artesunate is a primary treatment for severe malaria caused by Plasmodium species.
- Delayed hemolysis is a recognized but uncommon adverse effect of artesunate therapy.
- This complication typically manifests at least 7 days post-treatment.
Related Concept Videos
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...